PoliticsWorld NEWS
Weight loss, diabetes drugs propel Eli Lilly to better-than-expected forecast
The popular diabetes treatment Mounjaro pushed Eli Lilly past fourth-quarter forecasts, and the drugmaker expects 2024 to turn out largely better than expected too, as new products build momentumRead More Business